Study Provides “Molecular Roadmap” to How Asbestos Exposure Causes Mesothelioma

A collaborative study conducted by the renowned Sbarro Health Research Organization (SHRO) and the University of Siena in Italy has helped scientists better understand how asbestos exposure can lead to malignant pleural mesothelioma, the rare and deadly form of cancer that affects the lining of the lungs. The research provides an answer to the long-standing

Asbestos Mining Company Named in Mesothelioma Lawsuits Seeks Bankruptcy Protection

Asbestos Corporation Ltd. is a Canadian mining company that has been named as a defendant in thousands of mesothelioma and asbestos-related disease lawsuits in recent years. Founded in 1925 and headquartered in Thetford Mines, Quebec, the company has made a practice of refusing to participate in discovery proceedings in lawsuits filed against it, arguing that

Monitoring for Mesothelioma Leads to Increased Treatment Options 

The people being diagnosed with mesothelioma today had no idea they were being put at risk decades ago: Though asbestos companies were aware of their products’ toxicity, they issued no warnings and did nothing to protect employees or consumers. Though the rare form of cancer can’t be stopped from forming, those with known exposures can

USS Kenneth D. Bailey (DD-713) and Asbestos

The USS Kenneth D. Bailey (DD-713/DDR-713) was a Gearing class destroyer launched and commissioned in 1945. Though the ship didn’t deploy in the World War II combat she was built for, she played an integral role in the U.S. Navy’s later military history as a radar picket destroyer. Though the USS Kenneth D. Bailey served

USS Gyatt (DD-712) and Asbestos 

The USS Gyatt (DD-712/DDG-1/DDG-712) was a Gearing class destroyer launched and commissioned in 1945. Though the ship did not engage in the World War II combat she was built for, she played an integral role in the U.S. Navy’s military history as the world’s first guided missile destroyer. Despite this contribution, the Gyatt has also been linked

The WT1 Protein, the Galinpepimut-S Vaccine, and Mesothelioma

WT1 is a protein that is often present on the surface of pleural mesothelioma cells. After clinical trials found that galinpepimut-S (GPS), a WT1-specific vaccine, is safe and effective in causing programmed death in other malignancies where WT1 is present, researchers investigated the impact of combining GPS with nivolumab immunotherapy in previously treated mesothelioma. Preliminary results found that the

Preparing for Radiation Therapy for Mesothelioma 

Radiation therapy is frequently part of a multi-modality treatment plan for malignant mesothelioma. Radiation therapy is not an invasive procedure, but it does have potential side effects. Knowing how to prepare and how to manage potential side effects will help you through your treatment journey. Understanding Radiation Therapy’s Role in Treating Malignant Mesothelioma  Radiation therapy uses high-energy rays

Can a Vitamin-Rich Diet Improve Outcomes for Mesothelioma Patients?

Good nutrition is important for everybody, but especially for patients dealing with the challenges of malignant mesothelioma. While nutrition should not take priority over medical treatments, studies have shown that eating foods rich in certain vitamins can help reduce the side effects of treatments like chemotherapy, improve quality of life, and may even help boost the

UK Scientists to Explore Mesothelioma Latency

Researchers across the United Kingdom are recruiting participants for a mesothelioma study being funded by Cancer Research UK. The project, called Meso-ORIGINS, hopes to discover why mesothelioma’s tumors take decades to develop in people who have been exposed to asbestos.

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now